Vincent M. de Grandpré

Vincent M. de Grandpré

Osler, Hoskin & Harcourt LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

Generic Drug Company Licensees Avoid Patented Medicines Price Oversight

In nearly identical decisions released on May 27, 2014, Sandoz Canada Inc v Canada, 2014 FC 501 (Sandoz) and ratiopharm Inc v Canada, 2014 FC 502 (ratiopharm), the Federal Court of Canada held that some licensees of patents...more

6/11/2014 - Canada Generic Drugs Patents Pharmaceutical Pharmaceutical Patents Prescription Drugs

Methods of Medical Treatment: Still Not an “Invention” in Canada

On January 27, 2014, the Federal Court of Appeal in Novartis Pharmaceuticals Canada Inc. v. Cobalt Pharmaceuticals Co., 2014 FCA 17 (Novartis), upheld the Federal Court’s denial of an application for a prohibition order under...more

2/6/2014 - Canada Healthcare Patent Infringement Patent Litigation Patents

U.S. Supreme Court Holds That “Reverse Payment” Patent Litigation Settlements Are Not Immune from Antitrust Review

In a significant ruling involving both intellectual property rights and competition policy, the Supreme Court of the United States held in a 5–3 decision issued on June 17 that patent litigation settlements involving “reverse...more

6/19/2013 - Actavis Inc. FTC FTC v Actavis Generic Drugs Pay-For-Delay Pharmaceutical Prescription Drugs Reverse Payment Settlement Agreements SCOTUS Settlement

3 Results
|
View per page
Page: of 1